SMYD2 and cancer: In contrast, LLY-507 displayed anti-proliferative activity against cancer cell lines of all types tested (Fig 3D) irrespective of SMYD2 expression (S2 Fig), with the majority of cells demonstrating anti-proliferative IC50 values between 1 and 5 μM.